Hofu, Japan

Koichiro Miyake

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 5.7

ph-index = 5

Forward Citations = 226(Granted Patents)


Location History:

  • Yamaguchi, JP (2007)
  • Hofu, JP (2004 - 2009)

Company Filing History:


Years Active: 2004-2009

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Koichiro Miyake: Innovator in Isoprenoid Compound Production

Introduction

Koichiro Miyake is a prominent inventor based in Hofu, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of isoprenoid compounds. With a total of 6 patents to his name, Miyake's work has implications for pharmaceuticals and health products.

Latest Patents

Miyake's latest patents include a process for producing isoprenoid compounds by microorganisms. This invention focuses on utilizing DNA that encodes proteins to enhance the efficiency of biosynthesis for isoprenoid compounds. These compounds are vital for various applications, including treatments for cardiac diseases, osteoporosis, cancer prevention, and health food products. Another notable patent involves the production of ubiquinone-10 using specific microorganisms. This process highlights the importance of genetic properties in enhancing the production of valuable compounds.

Career Highlights

Miyake is associated with Kyowa Hakko Kogyo Co., Ltd., a company known for its advancements in biotechnology and pharmaceuticals. His work has positioned him as a key figure in the development of innovative processes that leverage microorganisms for compound production.

Collaborations

Miyake has collaborated with notable colleagues, including Akio Ozaki and Shinichi Hashimoto. These partnerships have contributed to the advancement of research and development in their respective fields.

Conclusion

Koichiro Miyake's innovative work in the production of isoprenoid compounds showcases his expertise and dedication to advancing biotechnology. His contributions continue to impact the pharmaceutical industry and health-related products.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…